glp 1 agonist addiction GLP-1 receptor agonists show promise in treating substance use disorders IUPHAR review – Glucagon-like peptide-1

Nature 414 , 799806 (2001)

[DOI] [PMC free article] [PubMed] [Google Scholar] 164.Gotfredsen CF, Molck AM, Thorup I, Nyborg NC, Salanti Z, Knudsen LB, Larsen MO

Stabilizing Anabolic Competence Preservation of lean mass is not merely a cosmetic endpoint but a central determinant of metabolic durability during weight reduction

Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: Systematic review and meta-analysis

Furthermore, the possible promotion of cancer cell growth is increasingly being discussed with contradictory results (Table 4) that require clarification

Cardiometabolic benefits may include better blood pressure and inflammation markers